Thomas Wegman, President and Chief Executive, 10% Owner at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 40,000 shares at $39.04 ($1.6M) on 2014-11-13, disclosed to the SEC on 2014-11-14.
Open-market sale of $1.6M BSTC by President and Chief Executive, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.08 | 27,700 | $1.1M | 69.5% |
| 2 | $39.04 | 4,300 | $168K | 10.8% |
| 3 | $38.50 | 8,000 | $308K | 19.8% |
| Total | $38.96 avg | 40,000 | $1.6M | 100% |
| Filing → |
| BSTC | SELL | 2016-12-13 | $743K | — | Filing → |
| BSTC | SELL | 2016-11-29 | $1.9M | — | Filing → |
| BSTC | SELL | 2016-09-16 | $128K | — | Filing → |